HOLX - Hologic, Inc.
BOSTON--(BUSINESS WIRE)--OM1 helped power a 650,000-patient real-world evidence study supporting FDA approval of Hologic's Aptima HPV Assay for cervical cancer screening.
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #WomensHealth--Research presented at the Society of Breast Imaging (SBI) Symposium backs Hologic AI-powered mammography technology for detecting challenging cancers.
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #holx--Blackstone and TPG Complete Acquisition of Hologic Accomplished MedTech leader Joe Almeida named Chief Executive Officer.
Hologic, Inc. (NASDAQ: HOLX - Get Free Report) saw some unusual options trading on Monday. Investors bought 3,509 put options on the company. This represents an increase of approximately 207% compared to the average daily volume of 1,144 put options. Institutional Investors Weigh In On Hologic Several hedge funds and other institutional investors have recently added
NEW YORK, April 6, 2026 /PRNewswire/ -- S&P MidCap 400 constituent Casey's General Stores Inc. (NASD: CASY) will replace Hologic Inc. (NASD: HOLX) in the S&P 500, S&P SmallCap 600 constituent DigitalOcean Holdings Inc. (NYSE: DOCN) will replace Casey's General Stores in the S&P MidCap 400, and Broadstone Net Lease Inc. (NYSE: BNL) will replace DigitalOcean Holdings in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 9. Affiliates of Blackstone Inc. and TPG Global are acquiring Hologic in a deal expected to be completed on or about April 7.
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Blackstone/TPG Acquisition.
Exchange Traded Concepts LLC lessened its stake in shares of Hologic, Inc. (NASDAQ: HOLX) by 46.5% in the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 13,488 shares of the medical equipment provider's stock after selling 11,714 shares during the period. Exchange Traded Concepts LLC's holdings in
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic, Inc. (NASDAQ: HOLX - Get Free Report)'s stock price reached a new 52-week high during trading on Thursday. The stock traded as high as $75.75 and last traded at $75.6350, with a volume of 31208 shares trading hands. The stock had previously closed at $75.52. Wall Street Analysts Forecast Growth Several analysts recently issued
Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
Hologic nears its $76 buyout price as Diagnostics faces headwinds, tariffs hurt, and the stock trades at a sector premium.
WASHINGTON--(BUSINESS WIRE)---- $HOLX #gallup--1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates.
Cinctive Capital Management LP increased its stake in Hologic, Inc. (NASDAQ: HOLX) by 53.4% in the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 66,404 shares of the medical equipment provider's stock after acquiring an additional 23,119 shares during the period. Cinctive Capital Management LP's holdings
Arrowpoint Investment Partners Singapore Pte. Ltd. bought a new stake in Hologic, Inc. (NASDAQ: HOLX) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 8,539 shares of the medical equipment provider's stock, valued at approximately $576,000. A number of other
HOLX expands its GYN Surgical reach with MyoSure, NovaSure and Gynesonics boost as the global women's health devices market grows and minimally invasive demand rises.
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
HOLX's Diagnostics unit faces COVID-19 test declines, but Panther Fusion expansion, new assays and AI-driven Genius system support long-term growth potential.
Becker Capital Management Inc. lifted its position in Hologic, Inc. (NASDAQ: HOLX) by 20.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 81,755 shares of the medical equipment provider's stock after buying an additional 13,610 shares during the period.